Page last updated: 2024-08-23

alovudine and Neoplasms

alovudine has been researched along with Neoplasms in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	27 (42.86)	29.6817
2010's	36 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aboagye, EO; Boellaard, R; Cysouw, MCF; De Langen, AJ; Frings, V; Hoekstra, OS; Kenny, LM; Kobe, C; Kramer, GM; Wolf, J; Wondergem, MJ	1
Jung, KH; Kang, KJ; Kim, JY; Kim, KM; Kim, MH; Ko, IO; Lee, KC; Lee, YJ; Lim, SM; Noh, I; Park, JA	1
Aboagye, EO; Asselin, MC; Boellaard, R; de Langen, AJ; Hoekstra, OS; Jackson, A; Jansma, EP; Kenny, L; Kramer, GM; Liu, Y; Trigonis, I	1
Binger, K; Bruce, JY; Carmichael, L; Dukart, G; Eickhoff, J; Harrow, K; Heideman, J; Jeraj, R; Kolesar, J; Liang, C; Liu, G; Perlman, S; Rampurwala, M; Scarpelli, M	1
Babur, M; Brown, G; Burrows, N; Cawthorne, C; Dive, C; Forster, D; Gieling, RG; Gregory, J; Hiscock, D; Hodgkinson, C; McMahon, A; Morrow, CJ; Radigois, M; Simpson, K; Smigova, A; Williams, KJ; Wilson, I	1
Ayers, GD; Coffey, RJ; Manning, HC; McKinley, ET; Saleh, SA; Smith, RA; Washington, MK; Zhao, P	1
Jeraj, R; Perlman, SB; Vanderhoek, M	1
Benz, MR; Buck, AK; Herrmann, K; Pomykala, KL; Wieder, HA	1
Buck, AK; Herrmann, K	1
Chalkidou, A; Fenwick, JD; Landau, DB; Liu, D; Marsden, PK	1
Armstrong, JO; Fink, JR; Friesen, A; Krohn, KA; Link, JM; Muzi, M; Peck, M; Pollack, HA; Shankland, EG; Shoner, SC	1
Kiyono, Y; Kume, K; Lin, C; Martinez, ME; Mori, T; Okazawa, H	1
Bezak, E; Jennings, M; Marcu, LG	1
Bruce, JY; Carmichael, LL; Eickhoff, JC; Heideman, JL; Jeraj, R; Kolesar, JM; Liu, G; Perlman, SB; Scully, PC	1
Bollineni, VR; Jansma, EP; Kramer, GM; Liu, Y; Oyen, WJ	1
Collins, JM; Douglas, KA; Jones, SK; Lawhorn-Crews, JM; Mangner, TJ; McHugh, CI; Modi, D; Shields, AF	1
Bruce, JY; Carmichael, L; Eickhoff, J; Jeraj, R; Kolesar, J; Liu, G; Perlman, S; Scarpelli, M	1
Aboagye, EO; Bollineni, VR; Heinzmann, K; Jacobs, AH; Kramer, GM; Liu, Y; Schelhaas, S; Shields, AF; Soloviev, D; Waterton, JC	1
Bading, JR; Shields, AF	1
Buck, AK; Dechow, T; Herrmann, K; Schwaiger, M; Shen, C; Wester, HJ	1
Han, DL; Jiang, WR; Yu, JM	1
Ahn, SH; Cheon, GJ; Choi, CW; Chun, KS; Kang, JH; Lee, TS; Lim, SM; Moon, BS	1
Avril, N; Barwick, T; Bencherif, B; Mountz, JM	1
Jackson, A; Trigonis, I	1
Atuegwu, NC; Gore, JC; Yankeelov, TE	1
Ametamey, SM; André, PA; Bischof Delaloye, A; Buchegger, F; Dupertuis, YM; Gruetter, R; Kosinski, M; Lanz, B; Lehr, HA; Mlynarik, V; Perillo-Adamer, F; Poitry-Yamate, C; Ross, TL; Viertl, D	1
Cass, CE; Gati, WP; Graham, K; Jans, HS; McEwan, A; McQuarrie, S; Mercer, J; Paproski, RJ; Wuest, M; Young, JD	1
Emerick, LE; Krohn, KA; Plotnik, DA; Schwartz, JL; Unadkat, JD	1
Brepoels, L; De Saint-Hubert, M; Mottaghy, FM	1
Benezra, R; Blasberg, RG; Escorcia, FE; Henke, E; McDevitt, MR; Scheinberg, DA; Smith-Jones, P; Villa, CH	1
Guleryuz, S; Manning, HC; Smith, RA	1
Chung, JH; Kang, HY; Kang, JS; Kim, HM; Kim, MH; Kim, SB; Kim, SY; Lee, SJ; Moon, DH; Oh, SJ; Park, SK; Ryu, JS	1
Conti, P; Graham, M; Hoffman, J	1
Bolen, JB; Chakravarty, A; Chen, W; Claiborne, CF; Ecsedy, JA; Germanos, MS; Gershman, RE; Hoar, KM; Huck, JJ; Hyer, ML; Janowick, DA; Leroy, PJ; Manfredi, MG; Sells, TB; Shinde, V; Silva, MD; Silverman, L; Stroud, SG; Wysong, DR; Zhang, M	1
Carmichael, L; Chao, B; Eickhoff, J; Harrison, M; Ivy, P; Jeraj, R; Kolesar, J; Liu, G; Marnocha, R; Perlman, S; Simoncic, U; Vanderhoek, M; Wilding, G	1
Affolter, T; Buckman, D; Christensen, JG; Cullinane, C; Fahey, NR; Kuszpit, K; Lappin, PB; Li, W; Lira, ME; Nichols, T; O'Brien, P; Painter, CL; Spilker, M; Wong, A; Yan, Z; Zasadny, K; Zhang, CC; Zhang, Q	1
Aboagye, E; Honess, D; Lewis, D; Soloviev, D	1
Shields, AF	2
Aboagye, E; Kimberley, S; Rosso, L; Tomasi, G; Turkheimer, F	1
Chalkidou, A; Cornelius, VR; Landau, DB; Marsden, PK; O'Doherty, MJ; Odell, EW	1
Flamen, P; Garcia, C; Gebhart, G	1
Aboagye, EO; Barthel, H; Brady, F; Cleij, MC; Collingridge, DR; He, Q; Hutchinson, OC; Luthra, SK; Osman, S; Price, PM	1
Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y	1
Cobben, DC; Elsinga, PH; Jager, PL; van Waarde, A	1
Aboagye, EO; Kenny, LM; Price, PM	1
Chatal, JF; Couturier, O; Hustinx, R	1
Been, LB; Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ	1
Grierson, JR; Krohn, KA; Mankoff, DA; Muzi, M; Vesselle, H; Wells, JM	1
Briston, DA; Chandupatla, S; Collins, JM; Douglas, KA; Heilbrun, LK; Lawhorn-Crews, J; Mangner, TJ; Muzik, O; Shields, AF	1
Carrió, I; Ell, PJ; Pakzad, F	1
Campone, M; Carlier, T; Chatal, JF; Couturier, O; Hustinx, R; Leost, F	1
de Korte, MA; de Vries, EG; Jager, PL; Koopmans, KP; Lub-de Hooge, MN; Perik, PJ; van Waarde, A	1
Deisenhofer, S; Reske, SN	1
Charnley, N; Price, P; Saleem, A	1
Chi, DY; Kil, HS; Kim, EN; Lee, SJ; Moon, DH; Oh, SJ; Ryu, JS	1
Kumar, R	1
Brockenbrough, JS; Grierson, JR; Jordan, R; Rasey, JS; Schwartz, JL; Vesselle, H; Wiens, LW	1
Ell, PJ; Groves, AM; Haim, SB; Win, T	1
Vallabhajosula, S	1
Grierson, J; Salskov, A; Tammisetti, VS; Vesselle, H	1
Dimitrakopoulou-Strauss, A; Strauss, LG	1
Eisenhut, M; Haberkorn, U; Mier, W	1

Reviews

25 review(s) available for alovudine and Neoplasms

Article	Year
Repeatability of quantitative European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:6 Topics: Dideoxynucleosides; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results	2018
PET tracers in musculoskeletal disease beyond FDG. Seminars in musculoskeletal radiology, 2014, Volume: 18, Issue:2 Topics: Amino Acids; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Choline; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Musculoskeletal Diseases; Neoplasms; Positron-Emission Tomography	2014
Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls. PET clinics, 2014, Volume: 9, Issue:3 Topics: Abdomen; Aging; Dideoxynucleosides; Fluorine Radioisotopes; Head; Humans; Neck; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thorax; Time Factors; Tissue Distribution; Tomography, X-Ray Computed; Urogenital System	2014
Applications of PET imaging with the proliferation marker [18F]-FLT. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2015, Volume: 59, Issue:1 Topics: Cell Proliferation; Dideoxynucleosides; Humans; Molecular Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine Kinase	2015
PET-specific parameters and radiotracers in theoretical tumour modelling. Computational and mathematical methods in medicine, 2015, Volume: 2015 Topics: Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Diffusion; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hydrogen-Ion Concentration; Hypoxia; Misonidazole; Models, Theoretical; Multimodal Imaging; Neoplasms; Neovascularization, Pathologic; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Tomography, X-Ray Computed	2015
A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients. European journal of cancer (Oxford, England : 1990), 2016, Volume: 55 Topics: Cell Proliferation; Dideoxynucleosides; Disease-Free Survival; Humans; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome	2016
Preclinical Applications of 3'-Deoxy-3'-[ Theranostics, 2017, Volume: 7, Issue:1 Topics: Animals; Dideoxynucleosides; Drug Evaluation, Preclinical; Drug Monitoring; Neoplasms; Positron Emission Tomography Computed Tomography	2017
Imaging of cell proliferation: status and prospects. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49 Suppl 2 Topics: Animals; Cell Proliferation; Dideoxynucleosides; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2008
[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:1 Topics: Dideoxynucleosides; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2009
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nuclear medicine communications, 2009, Volume: 30, Issue:12 Topics: Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Drug Evaluation, Preclinical; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome	2009
Imaging pharmacodynamics in oncology: the potential significance of "flares". Annals of nuclear medicine, 2010, Volume: 24, Issue:3 Topics: Animals; Biological Transport; Diagnostic Imaging; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasms; Pharmacokinetics; Radioactive Tracers	2010
Molecular imaging metrics to evaluate response to preclinical therapeutic regimens. Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:2 Topics: Diagnostic Imaging; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Thymidine Kinase	2011
[(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:4 Topics: Biomarkers, Pharmacological; Biomarkers, Tumor; Cell Proliferation; Diagnostic Imaging; Dideoxynucleosides; Humans; Neoplasms; Positron-Emission Tomography; Prognosis; Radioactive Tracers; Treatment Outcome	2012
Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:18 Topics: Antigens, Neoplasm; Bias; Biomarkers; Biopsy; Cell Division; Clinical Trials as Topic; Dideoxynucleosides; Female; Fluorine Radioisotopes; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Research Design; Surveys and Questionnaires; Tissue Distribution	2012
New PET imaging agents in the management of solid cancers. Current opinion in oncology, 2012, Volume: 24, Issue:6 Topics: Apoptosis; Cell Hypoxia; Cell Membrane; Cell Proliferation; Choline; Dideoxynucleosides; Heterocyclic Compounds, 1-Ring; Humans; Multimodal Imaging; Neoplasms; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Tissue Distribution; Tomography, X-Ray Computed	2012
Positron emission tomography imaging of cell proliferation in oncology. Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:3 Topics: Antiviral Agents; Cell Cycle; Cyclins; Dideoxynucleosides; DNA; Humans; Kinetics; Neoplasms; Phenotype; Thymidine; Tomography, Emission-Computed	2004
[Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography]. Bulletin du cancer, 2004, Volume: 91, Issue:9 Topics: Animals; Antiviral Agents; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Ganciclovir; Genes, Reporter; Genetic Therapy; Guanine; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Simplexvirus	2004
[18F]FLT-PET in oncology: current status and opportunities. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:12 Topics: Animals; Dideoxynucleosides; Humans; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index	2004
[Is 3'-deoxy-3'- [18F] fluorothymidine ([18F]-FLT) the next tracer for routine clinical PET after R [18F]-FDG?]. Bulletin du cancer, 2005, Volume: 92, Issue:9 Topics: Animals; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity	2005
Molecular imaging: what can be used today. Cancer imaging : the official publication of the International Cancer Imaging Society, 2005, Nov-23, Volume: 5 Spec No A Topics: Animals; Biochemical Phenomena; Biomarkers, Tumor; Diagnostic Imaging; Dideoxynucleosides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Cell Surface	2005
Clinical molecular imaging with positron emission tomography. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:12 Topics: Antineoplastic Agents; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2006
Non-[18F]FDG PET in clinical oncology. The Lancet. Oncology, 2007, Volume: 8, Issue:9 Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin	2007
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2007
[18F]FLT; portrait of a proliferation marker. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:2 Topics: Animals; Cell Division; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2002

Trials

4 trial(s) available for alovudine and Neoplasms

Article	Year
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel. Cancer chemotherapy and pharmacology, 2018, Volume: 82, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dideoxynucleosides; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasms; Oxindoles; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Vascular Endothelial Growth Factor A	2018
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:1 Topics: Adult; Aged; Axitinib; Dideoxynucleosides; Disease Progression; Female; Fluorine Radioisotopes; Humans; Imidazoles; Indazoles; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Substance Withdrawal Syndrome; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A	2015
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24 Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Dideoxynucleosides; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Indoles; Kidney; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasms; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A	2011
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:11 Topics: Computer Simulation; Dideoxynucleosides; Humans; Metabolic Clearance Rate; Models, Biological; Neoplasms; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution	2005

Other Studies

34 other study(ies) available for alovudine and Neoplasms

Article	Year
Baseline and longitudinal variability of normal tissue uptake values of [ Nuclear medicine and biology, 2017, Volume: 51 Topics: Biological Transport; Cell Proliferation; Dideoxynucleosides; Female; Humans; Image Processing, Computer-Assisted; Male; Neoplasms; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Retrospective Studies; Tissue Distribution	2017
Preliminary Contrast media & molecular imaging, 2017, Volume: 2017 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Fluorine-19 Magnetic Resonance Imaging; Heterografts; Humans; MCF-7 Cells; Mice; Neoplasms	2017
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941. Molecular cancer therapeutics, 2013, Volume: 12, Issue:5 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Female; HCT116 Cells; Humans; Indazoles; Mice; Neoplasm Metastasis; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Signal Transduction; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays	2013
Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. PloS one, 2013, Volume: 8, Issue:3 Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; HCT116 Cells; Humans; Immunohistochemistry; Mice; Mutation; Neoplasms; Positron-Emission Tomography; Thymidine; Transplantation, Heterologous	2013
Impact of different standardized uptake value measures on PET-based quantification of treatment response. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Biological Transport; Dideoxynucleosides; Humans; Neoplasms; Positron-Emission Tomography; Reference Standards; Treatment Outcome	2013
Interstitial diffusion and the relationship between compartment modelling and multi-scale spatial-temporal modelling of (18)F-FLT tumour uptake dynamics. Physics in medicine and biology, 2014, Sep-07, Volume: 59, Issue:17 Topics: Dideoxynucleosides; Humans; Models, Biological; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2014
Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:6 Topics: Animals; Carbon; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Radiation; Ions; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Particle Size; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tissue Distribution; X-Rays	2015
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Oct-17, Volume: 16, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Capecitabine; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2016
Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Axitinib; Dideoxynucleosides; Drug Administration Schedule; Female; Humans; Imidazoles; Indazoles; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor A	2016
Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine. Methods (San Diego, Calif.), 2009, Volume: 48, Issue:2 Topics: Animals; Cell Proliferation; Clinical Trials as Topic; Diagnosis, Differential; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecular Diagnostic Techniques; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2009
Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. Nuclear medicine and biology, 2009, Volume: 36, Issue:6 Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Positron-Emission Tomography; Rats; Thymidine Phosphorylase; Tissue Distribution; Tyrosine	2009
The integration of quantitative multi-modality imaging data into mathematical models of tumors. Physics in medicine and biology, 2010, May-07, Volume: 55, Issue:9 Topics: Annexin A5; Apoptosis; Cell Hypoxia; Cell Movement; Cell Proliferation; Diagnostic Imaging; Dideoxynucleosides; Diffusion; Logistic Models; Magnetic Resonance Imaging; Models, Biological; Neoplasms; Organotechnetium Compounds; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2010
Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomography. Molecular imaging and biology, 2011, Volume: 13, Issue:2 Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Flow Cytometry; Floxuridine; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Positron-Emission Tomography; Time Factors; Tissue Distribution; Xenograft Model Antitumor Assays	2011
Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:9 Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Female; Gene Knockdown Techniques; Gene Knockout Techniques; Humans; Mice; Mice, Knockout; Neoplasms; Positron-Emission Tomography; RNA, Messenger; RNA, Small Interfering; Spleen; Thioinosine; Thymidine; Thymidine Kinase; Transfection	2010
Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:9 Topics: Arabinofuranosyluracil; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Equilibrative Nucleoside Transport Proteins; Humans; Kinetics; Neoplasms; Positron-Emission Tomography; Thymidine; Tritium	2010
Can evaluation of targeted therapy in oncology be improved by means of 18F-FLT? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:10 Topics: Dideoxynucleosides; Drug Delivery Systems; Humans; Image Enhancement; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2010
Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors. Cancer research, 2010, Nov-15, Volume: 70, Issue:22 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dideoxynucleosides; Drug Synergism; Female; Fluorine Radioisotopes; Fluorouracil; Humans; Indium Radioisotopes; Leucovorin; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Tumor Burden; Xenograft Model Antitumor Assays	2010
Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:8 Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Humans; Male; Mice; Mitosis; Neoplasms; Positron-Emission Tomography; Protein Multimerization; Protein Structure, Quaternary; Thymidine Kinase; Time Factors; Tubulin; Tubulin Modulators; Tumor Burden; Xenograft Model Antitumor Assays	2011
SNM clinical trials network validates 100th scanner. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6 Topics: Clinical Trials as Topic; Dideoxynucleosides; Humans; Medical Oncology; Multicenter Studies as Topic; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed	2011
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24 Topics: Animals; Aurora Kinase A; Aurora Kinases; Azepines; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; HCT116 Cells; HeLa Cells; Humans; Lymphoma; Mice; Mice, Nude; Mice, SCID; Mitotic Index; Molecular Structure; Neoplasms; Phosphorylation; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Pyrimidines; Spindle Apparatus; Tumor Burden; Xenograft Model Antitumor Assays	2011
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-01, Volume: 18, Issue:5 Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Dideoxynucleosides; Disease Models, Animal; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Piperazines; Positron-Emission Tomography; Pyridines; Thymidine; Xenograft Model Antitumor Assays	2012
PET imaging of tumor growth: not as easy as it looks. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-01, Volume: 18, Issue:5 Topics: Animals; Dideoxynucleosides; Humans; Neoplasms; Positron-Emission Tomography	2012
Double-input compartmental modeling and spectral analysis for the quantification of positron emission tomography data in oncology. Physics in medicine and biology, 2012, Apr-07, Volume: 57, Issue:7 Topics: Dideoxynucleosides; Fluorouracil; Humans; Kinetics; Models, Biological; Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Spectrum Analysis; Statistics as Topic	2012
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer research, 2003, Jul-01, Volume: 63, Issue:13 Topics: Adenosine Triphosphate; Animals; Dideoxynucleosides; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasms; Neoplasms, Experimental; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous	2003
PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:9 Topics: Animals; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Neoplasm Staging; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymidine	2003
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:12 Topics: Animals; Arabinofuranosyluracil; Cell Division; Cell Line, Tumor; Dideoxynucleosides; DNA; Drug Delivery Systems; Humans; Metabolic Clearance Rate; Mice; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Tomography, Emission-Computed; Tritium	2003
Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003. Cancer research, 2003, Dec-01, Volume: 63, Issue:23 Topics: Dideoxynucleosides; Drug Monitoring; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:2 Topics: Algorithms; Cell Proliferation; Computer Simulation; Dideoxynucleosides; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Neoplasm Staging; Neoplasms; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution	2005
Molecular imaging in animal models of disease--every little detail counts! European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:8 Topics: Animals; Artifacts; Dideoxynucleosides; Dogs; Humans; Mice; Molecular Probe Techniques; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Sensitivity and Specificity; Species Specificity; Tissue Distribution	2005
Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose? European journal of nuclear medicine and molecular imaging, 2006, Volume: 33 Suppl 1 Topics: Animals; Antineoplastic Agents; Dideoxynucleosides; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms; Radionuclide Imaging; Reproducibility of Results	2006
Simple and highly efficient synthesis of 3'-deoxy-3'-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:9 Topics: Automation; Cell Proliferation; Chromatography, Thin Layer; Dideoxynucleosides; Fluorine Radioisotopes; Halogenation; Humans; Neoplasms; Quality Control; Radiochemistry; Radiopharmaceuticals; Solvents; Temperature; Time Factors	2007
Assessment of therapy response in malignant tumours with 18F-fluorothymidine. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:9 Topics: Antineoplastic Agents; Clinical Trials as Topic; Dideoxynucleosides; Humans; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2007
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity. Nuclear medicine and biology, 2007, Volume: 34, Issue:5 Topics: Cell Line, Tumor; Dideoxynucleosides; Enzyme Activation; Humans; Metabolic Clearance Rate; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thymidine Phosphorylase; U937 Cells	2007
The role of 18F-FLT in cancer imaging: does it really reflect proliferation? European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:3 Topics: Animals; Cell Proliferation; Dideoxynucleosides; Humans; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2008

chemdatabank.com